2612 Granby Street
Norfolk, VA 23517
United States
646-926-3568
https://www.amelotholdings.com
Secteur(s): Healthcare
Secteur d’activité: Drug Manufacturers - Specialty & Generic
Employés à temps plein:
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Dr. Anna Petinova | Interim Vice President of Administration, Interim Vice President of Finance, Treasurer and Director | S.O. | S.O. | 1964 |
Mr. Hank Midden | Vice President - Operations | S.O. | S.O. | 1942 |
Mr. John Gernannt | Head of Investor & Public Relations Issues | S.O. | S.O. | S.O. |
Mr. Peter R. N. Maharaj | Vice President - Marketing and President - Southern Hardwoods | S.O. | S.O. | 1966 |
Mr. Thomas Cripe | Senior Vice President of Business & Technology Development | S.O. | S.O. | S.O. |
Mr. Tyler Macallister | Controller | S.O. | S.O. | S.O. |
HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. It also acquires real estate properties. The company was formerly known as Amelot Holdings, Inc. and changed its name to HLK Biotech Holding Group, Inc. in February 2018. HLK Biotech Holding Group, Inc. was incorporated in 1998 and is headquartered in Norfolk, Virginia.
L’ISS Governance QualityScore de HLK Biotech Holding Group, Inc. en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..